Sangamo Biosciences, Inc. (NASDAQ:SGMO)
CAPS Rating:
The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.
The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.
Recs
great price to buy in at & be patient for the incubation period to reap great benefit